Goldman Sachs
GUTS icon

Goldman Sachs’s Fractyl Health GUTS Stock Holding History

Goldman Sachs’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
14,655
+8,952
+157% +$76.5K ﹤0.01% 6285
2026
Q1 		$31.3K Sell
5,703
-279,730
-98% -$3.09M ﹤0.01% 6333
2025
Q4 		$7.54M Buy
285,433
+244,562
+598% +$4.72M ﹤0.01% 3360
2025
Q3 		$780K Buy
40,871
+29,116
+248% +$453K ﹤0.01% 5206
2025
Q2 		$229K Buy
11,755
+4,436
+61% +$86K ﹤0.01% 5593
2025
Q1 		$105K Sell
7,319
-3,522
-32% -$67.5K ﹤0.01% 5779
2024
Q4 		$268K Buy
10,841
+5,877
+118% +$164K ﹤0.01% 5533
2024
Q3 		$151K Buy
4,964
+3,429
+223% +$134K ﹤0.01% 5517
2024
Q2 		$78.7K Buy
+1,535
New +$119K ﹤0.01% 5425

Other funds holding GUTS

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Catalio Capital Management
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Pale Fire Capital SE
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
General Catalyst Group Management
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
Deer Management Company
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
M28 Capital Management
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs's GUTS Position: Q2 2026 in Review

Goldman Sachs increased its Fractyl Health (GUTS) stake by 157% in Q2 2026, buying an estimated $76.5K and bringing the position to 14,655 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #6285.

Goldman Sachs first reported a position in GUTS in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.54M in Q4 2025. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Goldman Sachs held 14,655 shares of Fractyl Health worth $140K as of Q2 2026.
  • Goldman Sachs bought 8,952 Fractyl Health shares in Q2 2026, an estimated $76.5K.
  • Fractyl Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6285 holding.
  • Goldman Sachs first reported a position in Fractyl Health in Q2 2024 and has held it in 9 quarters since.
  • Goldman Sachs's Fractyl Health position peaked at $7.54M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.